ATR pathway inhibition is synthetically lethal in cancer cells with ERCC1 deficiency.

Abstract:

:The DNA damage response kinase ATR and its effector kinase CHEK1 are required for cancer cells to survive oncogene-induced replication stress. ATR inhibitors exhibit synthetic lethal interactions, with deficiencies in the DNA damage response enzymes ATM and XRCC1 and with overexpression of the cell cycle kinase cyclin E. Here, we report a systematic screen to identify synthetic lethal interactions with ATR pathway-targeted drugs, rationalized by their predicted therapeutic utility in the oncology clinic. We found that reduced function in the ATR pathway itself provided the strongest synthetic lethal interaction. In addition, we found that loss of the structure-specific endonuclease ERCC1-XPF (ERCC4) is synthetic lethal with ATR pathway inhibitors. ERCC1-deficient cells exhibited elevated levels of DNA damage, which was increased further by ATR inhibition. When treated with ATR or CHEK1 inhibitors, ERCC1-deficient cells were arrested in S-phase and failed to complete cell-cycle transit even after drug removal. Notably, triple-negative breast cancer cells and non-small cell lung cancer cells depleted of ERCC1 exhibited increased sensitivity to ATR pathway-targeted drugs. Overall, we concluded that ATR pathway-targeted drugs may offer particular utility in cancers with reduced ATR pathway function or reduced levels of ERCC4 activity.

journal_name

Cancer Res

journal_title

Cancer research

authors

Mohni KN,Kavanaugh GM,Cortez D

doi

10.1158/0008-5472.CAN-13-3229

subject

Has Abstract

pub_date

2014-05-15 00:00:00

pages

2835-45

issue

10

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-13-3229

journal_volume

74

pub_type

杂志文章
  • Batracylin (NSC 320846), a dual inhibitor of DNA topoisomerases I and II induces histone gamma-H2AX as a biomarker of DNA damage.

    abstract::Batracylin (8-aminoisoindolo [1,2-b]quinazolin-10(12H)-one; NSC320846) is an investigational clinical anticancer agent. Previous animal studies showed activity against solid tumors and Adriamycin-resistant leukemia. We initially sought to test the proposed Top2-mediated DNA cleavage activity of batracylin and identify...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-0804

    authors: Rao VA,Agama K,Holbeck S,Pommier Y

    更新日期:2007-10-15 00:00:00

  • Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.

    abstract::Estrogen sulfotransferase (EST; SULT 1E1 or STE gene) sulfonates estrogens to inactive estrogen sulfates, whereas steroid sulfatase (STS) hydrolyzes estrone sulfate to estrone. Both EST and STS have been suggested to play important roles in regulating the in situ production of estrogens in human breast carcinoma tissu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Suzuki T,Nakata T,Miki Y,Kaneko C,Moriya T,Ishida T,Akinaga S,Hirakawa H,Kimura M,Sasano H

    更新日期:2003-06-01 00:00:00

  • Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.

    abstract::Murine melanoma B16-F1 cells of low metastatic potential were transfected with the human gene for the prepro form of urokinase in an SV40 expression vector (plasmid pSV2-uPA), and cells expressing high amounts of the human urokinase gene product were selected for by an enzyme-linked immunosorbent assay specific for hu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yu HR,Schultz RM

    更新日期:1990-12-01 00:00:00

  • Yeast topoisomerase II mutants resistant to anti-topoisomerase agents: identification and characterization of new yeast topoisomerase II mutants selected for resistance to etoposide.

    abstract::We describe a system that allows us to easily isolate and characterize mutants in yeast topoisomerase II that are resistant to antitumor agents that target this enzyme. The system uses yeast strains that are sensitive to those agents and that carry temperature-sensitive top2 mutations. The temperature-sensitive mutati...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Liu YX,Hsiung Y,Jannatipour M,Yeh Y,Nitiss JL

    更新日期:1994-06-01 00:00:00

  • Gastric and intestinal phenotypic expressions of human signet ring cell carcinomas revealed by their biochemistry, mucin histochemistry, and ultrastructure.

    abstract::Gastric and intestinal phenotypic expression in 37 surgically obtained primary signet ring cell carcinomas, five of their metastases to lymph nodes, and three signet ring cell carcinomas transplanted into nude mice were determined by biochemical, mucin, histochemical, and ultrastructural studies. Crude extracts of can...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tatematsu M,Furihata C,Katsuyama T,Miki K,Honda H,Konishi Y,Ito N

    更新日期:1986-09-01 00:00:00

  • The 43000 growth-associated protein functions as a negative growth regulator in glioma.

    abstract::Previous molecular analyses of human astrocytomas have identified many genetic changes associated with astrocytoma formation and progression. In an effort to identify novel gene expression changes associated with astrocytoma formation, which might reveal new potential targets for glioma therapeutic drug design, we use...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Huang ZY,Wu Y,Burke SP,Gutmann DH

    更新日期:2003-06-01 00:00:00

  • Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.

    abstract::(+-)-2-[Hydroxy[tetrahydro-2-(octadecyloxy)methylfuran-2- yl]methoxyl]phosphinyloxy-N,N,N-trimethylethaniminium hydroxide, inner salt (SRI 62-834) is a tetrahydrofuran analogue of platelet activating factor (PAF) that is currently entering clinical trial. Like other ether lipids it is of interest as a membrane-active ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dive C,Watson JV,Workman P

    更新日期:1991-02-01 00:00:00

  • CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy.

    abstract::The therapeutic efficacy of anthracyclines relies, at least partially, on the induction of a dendritic cell- and T-lymphocyte-dependent anticancer immune response. Here, we show that anthracycline-based chemotherapy promotes the recruitment of functional CD11b(+)CD11c(+)Ly6C(high)Ly6G(-)MHCII(+) dendritic cell-like an...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1265

    authors: Ma Y,Mattarollo SR,Adjemian S,Yang H,Aymeric L,Hannani D,Portela Catani JP,Duret H,Teng MW,Kepp O,Wang Y,Sistigu A,Schultze JL,Stoll G,Galluzzi L,Zitvogel L,Smyth MJ,Kroemer G

    更新日期:2014-01-15 00:00:00

  • Protein tyrosine phosphatase Shp2 (Ptpn11) plays an important role in maintenance of chromosome stability.

    abstract::Both activating and inactivating mutations in protein tyrosine phosphatase Ptpn11 (encoding Shp2) are associated with tumorigenesis. However, the underlying mechanisms remain unclear. Here, we show that Shp2 plays an important role in mitosis, dysregulation of which results in chromosome instability and cancer predisp...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-1495

    authors: Liu X,Zheng H,Qu CK

    更新日期:2012-10-15 00:00:00

  • Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.

    abstract::Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD) could function as a cell surface sensor for cell density, controlling the transition between local cell proliferation and tissue invasion in melanoma progression. We have tested the hypothesis that progressive cell clustering controls the proteolytic cascad...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0378

    authors: Lunter PC,van Kilsdonk JW,van Beek H,Cornelissen IM,Bergers M,Willems PH,van Muijen GN,Swart GW

    更新日期:2005-10-01 00:00:00

  • Establishment and characterization of four new human non-small cell lung cancer cell lines.

    abstract::Four new human non-small cell lung cancer cell lines have been established in vitro. These cell lines have been characterized by (a) growth of a tumor in nude mice with histopathology similar to that of the primary, (b) isoenzyme patterns phenotypically human and distinct from each other, (c) distinguishing karyotypic...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Loh PM,Clamon GH,Robinson RA,White ML,Hukku B,Rossi NP,Peterson WD

    更新日期:1984-08-01 00:00:00

  • Plant-derived human papillomavirus 16 E7 oncoprotein induces immune response and specific tumor protection.

    abstract::Vaccine strategies for treatment of human papillomavirus-induced cervical cancer are based on either the recombinant E7 fusion oncoprotein or E7 CTL peptides. The therapeutic potential of the E7-based vaccine depends on the use of different adjuvants. In this study, we describe for the first time the expression of the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Franconi R,Di Bonito P,Dibello F,Accardi L,Muller A,Cirilli A,Simeone P,Donà MG,Venuti A,Giorgi C

    更新日期:2002-07-01 00:00:00

  • Roles for Innate Immunity in Combination Immunotherapies.

    abstract::Immunity to infectious agents involves a coordinated response of innate and adaptive immune cells working in concert, with many feed-forward and regulatory interactions between both arms of the immune system. In contrast, many therapeutic strategies to augment immunity against tumors have focused predominantly on stim...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-17-1340

    authors: Moynihan KD,Irvine DJ

    更新日期:2017-10-01 00:00:00

  • Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer.

    abstract::Myeloid-derived suppressor cells (MDSC) expand in tumor-bearing hosts and play a central role in cancer immune evasion by inhibiting adaptive and innate immunity. They therefore represent a major obstacle for successful cancer immunotherapy. Different strategies have thus been explored to deplete and/or inactivate MDS...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1545

    authors: Alizadeh D,Trad M,Hanke NT,Larmonier CB,Janikashvili N,Bonnotte B,Katsanis E,Larmonier N

    更新日期:2014-01-01 00:00:00

  • Altered expression of neurotensin receptors is associated with the differentiation state of prostate cancer.

    abstract::In prostate cancer, traditional treatments such as androgen response manipulation often provide only temporary resolution of disease, with emergence of a more aggressive, androgen-independent tumor following initial therapy. To treat recurrent disease, cell surface proteins that are specifically overexpressed on malig...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-1252

    authors: Swift SL,Burns JE,Maitland NJ

    更新日期:2010-01-01 00:00:00

  • Comparative analyses of transgene delivery and expression in tumors inoculated with a replication-conditional or -defective viral vector.

    abstract::Viral vectors for cancer can be classified into those that do not replicate (replication-defective vectors) and those that selectively replicate in neoplastic cells (replication-conditional or oncolytic vectors). Both of these can deliver anticancer cDNAs for therapeutic purposes. Opposite hypotheses can be made regar...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ichikawa T,Chiocca EA

    更新日期:2001-07-15 00:00:00

  • beta(3) Integrin subunit mediates the bone-resorbing function exerted by cultured myeloma plasma cells.

    abstract::alpha(v)beta(3) integrin was investigated in multiple myeloma in relation to the in vitro osteoclast-like activity of malignant plasma cells. Myeloma cells from patients with skeleton involvement overexpressed alpha(v)beta(3) and produced erosion pits on bone substrates, whereas this effect was not observed by cells f...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-0949

    authors: Tucci M,De Palma R,Lombardi L,Rodolico G,Berrino L,Dammacco F,Silvestris F

    更新日期:2009-08-15 00:00:00

  • Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.

    abstract::Two populations of nuclear androgen receptors have been characterized in human prostatic tissue, and the levels and proportions of each were found to differ in normal prostates, benign hyperplastic prostates (BPH), and malignant prostates. A significant percentage (35 to 50%) of total nuclear androgen receptors was as...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Barrack ER,Bujnovszky P,Walsh PC

    更新日期:1983-03-01 00:00:00

  • Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers.

    abstract::Estrogen exposure is considered a significant risk factor for breast cancer development. Estrogen receptor (ER) alpha is expressed at low levels in normal epithelia, and its expression is dramatically up-regulated as transformation progresses during mammary hyperplasia and adenocarcinoma development. The mechanism(s) ...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-06-2805

    authors: Sotgia F,Rui H,Bonuccelli G,Mercier I,Pestell RG,Lisanti MP

    更新日期:2006-11-15 00:00:00

  • Positive correlation between calmodulin content and hepatoma growth rates.

    abstract::Calmodulin contents of normal rat liver, host liver [bearing hepatoma 5123t.c.(h)], regenerating liver, and Morris hepatomas 7800, 5123t.c.(h), and 7794A were determined by phosphodiesterase assay and by radioimmunoassay. The calmodulin levels determined by both assays were significantly increased in three hepatomas w...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wei JW,Morris HP,Hickie RA

    更新日期:1982-07-01 00:00:00

  • Pheophorbide a is a specific probe for ABCG2 function and inhibition.

    abstract::Pheophorbide a (PhA), a chlorophyll catabolite, was shown to be an ABCG2 substrate based on Abcg2(-/-) knockout mouse studies (J. W. Jonker et al., Proc. Natl. Acad. Sci. USA, 99: 15649-15654, 2002). We developed a functional assay for ABCG2 using PhA and the ABCG2 inhibitor fumitremorgin C. In selected cell lines exp...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.can-03-3298

    authors: Robey RW,Steadman K,Polgar O,Morisaki K,Blayney M,Mistry P,Bates SE

    更新日期:2004-02-15 00:00:00

  • Assessment of reactivities of natural antibodies to endogenous RNA tumor virus envelope antigens and virus-induced cell surface antigens.

    abstract::The autogenous humoral immune response of mice to their endogenous leukemia virus (MuLV) has been examined with respect to the reactivities of natural antibodies to MuLV envelope antigens and virus-induced cells surface antigens. The natural reactivity of MuLV envelope antigens was evaluated by means of a radioimmune ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hanna MG Jr,Ihle JN,Batzing BL,Tennant TW,Schenley CK

    更新日期:1975-01-01 00:00:00

  • NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.

    abstract::The NY-ESO-1 gene product is expressed by a range of human tumors and is recognized by antibodies from sera of cancer patients with NY-ESO-1-expressing tumors. The NY-ESO-1 gene also encodes several MHC class I- and MHC class II-restricted tumor epitopes recognized by T lymphocytes. In particular, we previously report...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zarour HM,Maillere B,Brusic V,Coval K,Williams E,Pouvelle-Moratille S,Castelli F,Land S,Bennouna J,Logan T,Kirkwood JM

    更新日期:2002-01-01 00:00:00

  • Dissimilar effects of phorbol ester and diacylglycerol derivative on protein kinase activity in the monoblastoid U937 cell.

    abstract::Mechanism, in addition to protein kinase C activation may mediate 12-O-tetradecanoylphorbol-13-acetate (TPA) stimulated differentiation of leukemic cells. We compared the effect of pretreating intact monoblastoid U937 cells with TPA or the diacylglycerol derivative, 1-oleoyl-2-acetylglycerol (OAG), by studying the pro...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ways DK,Dodd RC,Earp HS

    更新日期:1987-07-01 00:00:00

  • Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.

    abstract::Recent studies have demonstrated the presence of microsatellite instability (MSI) in tumors from patients with hereditary nonpolyposis colon cancer and in a subset of patients with sporadic colorectal cancer (CRC). In sporadic CRC, three tumor phenotypes have been defined: microsatellite stable (MSS), low-frequency MS...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cunningham JM,Christensen ER,Tester DJ,Kim CY,Roche PC,Burgart LJ,Thibodeau SN

    更新日期:1998-08-01 00:00:00

  • Inhibition of 2-Amino-1-methyl-6-phenylimidazo[4,5]pyridine-induced lymphoma formation by oltipraz.

    abstract::2-Amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is a mutagenic and carcinogenic heterocyclic amine present in pyrolysate products of meat and fish and has been shown to induce tumors in the colon, mammary gland, and possibly lymphatic system. Experiments were designed to examine the lymphoma-inducing capacity o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rao CV,Rivenson A,Zang E,Steele V,Kelloff G,Reddy BS

    更新日期:1996-08-01 00:00:00

  • CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells.

    abstract::Genetic immunization of mice with dendritic cells (DCs) engineered to express a melanoma antigen generates antigen-specific, MHC-restricted, CD4-dependent protective immune responses. We wanted to determine the role of CD4 cells and CD40 ligation of MART-1 gene-modified DC in an animal model of immunotherapy for murin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ribas A,Butterfield LH,Amarnani SN,Dissette VB,Kim D,Meng WS,Miranda GA,Wang HJ,McBride WH,Glaspy JA,Economou JS

    更新日期:2001-12-15 00:00:00

  • Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.

    abstract::A correlation exists between the ability of tumor cells to aggregate platelets and their tendency to metastasize. Tumor cell-induced platelet aggregation (TCIPA) facilitates the embolization of the vasculature with tumor cells and the formation of metastatic foci. It is well documented that matrix metalloproteinases (...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jurasz P,Sawicki G,Duszyk M,Sawicka J,Miranda C,Mayers I,Radomski MW

    更新日期:2001-01-01 00:00:00

  • Serine/arginine protein-specific kinase 2 promotes leukemia cell proliferation by phosphorylating acinus and regulating cyclin A1.

    abstract::Serine/arginine (SR) protein-specific kinase (SRPK), a family of cell cycle-regulated protein kinases, phosphorylate SR domain-containing proteins in nuclear speckles and mediate the pre-mRNA splicing. However, the physiologic roles of this event in cell cycle are incompletely understood. Here, we show that SRPK2 bind...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0021

    authors: Jang SW,Yang SJ,Ehlén A,Dong S,Khoury H,Chen J,Persson JL,Ye K

    更新日期:2008-06-15 00:00:00

  • The identification of phorbolol myristate acetate as a new metabolite of phorbol myristate acetate in mouse skin.

    abstract::Aspects of the metabolism of phorbol myristate acetate (PMA) in mouse skin were investigated. Phorbolol myristate acetate (PHMA), a potential metabolite of PMA in mouse skin, was prepared from PMA by NaBH4 reduction of the C-5 carbonyl group of PMA to a secondary alcohol. The structure of PHMA was assigned on the basi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Segal A,Van Duuren BL,Maté U

    更新日期:1975-08-01 00:00:00